Companies
Kenvue
Consumer goodsSummit, New JerseyKVUEAbout 22,000 employees
More about Kenvue
Consumer health company selling over-the-counter medicines, skin care and personal care products, spun off from Johnson & Johnson in 2023
Revenue
$15.1B
2025, down 2.1%
Employees
About 22,000
As of December 2025
Stock
KVUE
New York Stock Exchange
Headquarters
Summit, New Jersey
CEO
Kirk Perry
Since November 2025; interim CEO from July 2025
BrandsTylenol, Neutrogena, Listerine, Band-Aid, Aveeno, Johnson's, Zyrtec
Current strategyAgreed in November 2025 to be acquired by Kimberly-Clark, with closing expected in the fourth quarter of 2026, while simplifying its operating model and supply chain
Recent workforce changesNet global workforce reduction of about 3.5% approved in February 2026
CompetitorsHaleon, Procter & Gamble, Bayer
Related companiesKimberly-ClarkJohnson & JohnsonProcter & Gamble
Checked October 11, 2026 · Sources: sec.gov, sec.gov (2), sec.gov (3), sec.gov (4)
No source-backed updates for Kenvue yet. They appear here when a public report or filing covers the company.
No one has posted about Kenvue yet. Be the first to post ›
Follow Kenvue in a feed reader, no account needed: RSS feed